OptiNose, Inc.

Ownership Transactions Reported by 19 Insiders

Symbol
OPTN on Nasdaq
Industry
Pharmaceutical Preparations
Location
777 Township Line Road, Suite 300, Yardley, Pennsylvania

Insiders trading volume in the past year

OptiNose, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
MVM Partners, LLC 10%+ Owner $16.8 M Dec 31, 2022
MVM Partners LLP 10%+ Owner $14.4 M Nov 18, 2021
Ramy A. Mahmoud Chief Executive Officer, Director $1.77 M -$156 K -8.08% Jun 15, 2024
Peter K. Miller Chief Executive Officer, Director $1.1 M Jan 13, 2023
Michael F. Marino III Chief Legal Officer & Corp Sec $714 K -$48.3 K -6.34% Jun 18, 2024
Paul Spence Jr. Chief Commercial Officer $331 K Feb 28, 2024
Victor M. Clavelli Chief Commercial Officer $230 K Dec 15, 2022
Anthony J. Krick Chief Accounting Officer $171 K -$5.15 K -2.93% Jun 18, 2024
Keith A. Goldan Chief Financial Officer $163 K Mar 16, 2022
Michele Janis Acting Chief Financial Officer $56.3 K Dec 15, 2022
Avista Capital Partners II GP, LLC 10%+ Owner $55.6 K May 12, 2023
Eric Bednarski Director Jun 6, 2024
Tomas J. Heyman Director Jun 6, 2024
E. Owen Director Jun 6, 2024
Joseph C. Scodari Director Jun 8, 2022
Kyle Dempsey Director Jun 6, 2024
Sandra L. Helton Director Jun 6, 2024
R. John Fletcher Director Jun 6, 2024
Wilhelmus Cm Groenhuysen Director Jun 6, 2024

Recent Insider Transactions by Companies or Individuals for OptiNose, Inc.

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership